INTERNATIONAL PATENT: MONTE ROSA THERAPEUTICS AG FILES APPLICATION FOR "CYCLOPROPYL AND 1,3,4-OXODIAZOLE COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF"

GENEVA, Sept. 8 -- MONTE ROSA THERAPEUTICS AG (Klybeckstrasse 191WKL-136.34057 Basel) filed a patent application (PCT/EP2025/055383) for "CYCLOPROPYL AND 1,3,4-OXODIAZOLE COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF" on Feb 27, 2025. With publication no. WO/2025/181261, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FASCHING, Bernhard (c/o Monte Rosa Therapeutics AGKlybeckstrasse 191WKL-136.34057 Basel), MCALLISTER, Laura Ann (c/o Monte Rosa Therapeutics AGKlybeckstrasse 191WKL-136.34057 Basel), ...